Clinical correlates of sex steroids and gonadotropins in men over the late adulthood: The Framingham Heart Study

International Journal of Andrology

Volumn 35, Issue 6, 2012, Pages 775-782

  Haring, R ^a,b   Xanthakis, V ^a,c   Coviello, A ^a   Sullivan, L ^a   Bhasin, S ^a   Wallaschofski, H ^b   Murabito, J M ^a,c   Vasan, R S ^a,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^c FRAMINGHAM HEART STUDY   (United States)

Author keywords

Ageing male; Framingham Heart Study; Gonadotropins; Sex steroids; Testosterone

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADOTROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE; TESTOSTERONE;

AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL STUDY; FOLLOW UP; HORMONE DETERMINATION; HUMAN; LABORATORY TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

AGED; CARDIOVASCULAR DISEASES; GONADAL STEROID HORMONES; GONADOTROPINS; HUMANS; LONGITUDINAL STUDIES; MALE; MASSACHUSETTS; MIDDLE AGED;

EID: 84869877474     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2012.01285.x     Document Type: Article

References (49)

1. Amin S, Zhang Y, Sawin CT, Evans SR, Hannan MT, Kiel DP, Wilson PW & Felson D T. (2000) Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann Intern Med 133, 951-963.
2. Andersson AM, Jensen TK, Juul A, Petersen JH, Jorgensen T & Skakkebaek NE. (2007) Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys. J Clin Endocrinol Metab 92, 4696-4705.
3. Araujo AB, Kupelian V, Page ST, Handelsman DJ, Bremner WJ & McKinlay JB. (2007) Sex steroids and all-cause and cause-specific mortality in men. Arch Int Med 167, 1252-1260.
4. Barrett-Connor E & Khaw KT. (1988) Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation 78, 539-545.
5. Barrett-Connor E, Khaw KT & Yen SS. (1986) A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. New England J Med 315, 1519-1524.
6. Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM et al. (2010) Adverse events associated with testosterone administration. New England J Med 363, 109-122.
7. Cappola AR, O'Meara ES, Guo W, Bartz TM, Fried LP & Newman AB. (2009) Trajectories of dehydroepiandrosterone sulfate predict mortality in older adults: the cardiovascular health study. J Gerontol 64, 1268-1274.
8. Corona G, Monami M, Rastrelli G, Aversa A, Sforza A, Lenzi A, Forti G, Mannucci E & Maggi M. (2011) Type 2 diabetes mellitus and testosterone: a meta-analysis study. Int J Androl 34, 528-540.
9. Dawber TR, Meadors GF & Moore FE, Jr. (1951) Epidemiological approaches to heart disease: the Framingham Study. Am J Pub Health Nation's Health 41, 279-281.
10. Derby CA, Zilber S, Brambilla D, Morales KH & McKinlay JB. (2006) Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) 65, 125-131.
11. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ & McKinlay JB. (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Cli Endocrinol Metab 87, 589-598.
12. Gray A, Feldman HA, McKinlay JB & Longcope C. (1991) Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 73, 1016-1025.
13. Haffner SM, Mykkanen L, Valdez RA & Katz MS. (1993) Relationship of sex hormones to lipids and lipoproteins in nondiabetic men. J Clin Endocrinol Metab 77, 1610-1615.
14. Hakimian P, Blute M, Jr, Kashanian J, Chan S, Silver D & Shabsigh R. (2008) Metabolic and cardiovascular effects of androgen deprivation therapy. BJU Int 102, 1509-1514.
15. Haring R, Volzke H, Felix SB, Schipf S, Dorr M, Rosskopf D, Nauck M, Schofl C & Wallaschofski H. (2009) Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania. Diabetes 58, 2027-2031.
16. Haring R, Ittermann T, Volzke H, Krebs A, Zygmunt M, Felix SB, Grabe HJ, Nauck M & Wallaschofski H. (2010a) Prevalence, incidence and risk factors of testosterone deficiency in a population-based cohort of men: results from the study of health in Pomerania. Aging Male 13, 247-257.
17. Haring R, Volzke H, Steveling A, Krebs A, Felix SB, Schofl C, Dorr M, Nauck M & Wallaschofski H. (2010b) Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. Eur Heart J 31, 1494-1501.
18. Haring R, Baumeister SE, Völzke H, Dorr M, Felix SB, Kroemer HK, Nauck M & Wallaschofski H. (2011) Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia. Eur J Cardiovasc Prev Rehabil 18, 86-96.
19. Harman SM, Metter EJ, Tobin JD, Pearson J & Blackman MR. (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86, 724-731.
20. Kannel WB, Feinleib M, McNamara PM, Garrison RJ & Castelli WP. (1979) An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 110, 281-290.
21. Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, Welch A & Day N. (2007) Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 116, 2694-2701.
22. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ & McKinlay JB. (2006) Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 91, 843-850.
23. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP & Salonen JT. (2005) The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. J Clin Endocrinol Metab 90, 712-719.
24. Lapauw B, Goemaere S, Zmierczak H, Van Pottelbergh I, Mahmoud A, Taes Y, De Bacquer D, Vansteelandt S & Kaufman JM. (2008) The decline of serum testosterone levels in community-dwelling men over 70years of age: descriptive data and predictors of longitudinal changes. Eu J Endocrinol / Eur Federation of Endocrine Soc 159, 459-468.
25. Laughlin GA, Barrett-Connor E & Bergstrom J. (2008) Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 93, 68-75.
26. Leifke E, Gorenoi V, Wichers C, Von Zur Muhlen A, Von Buren E & Brabant G. (2000) Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin Endocrinol (Oxf) 53, 689-695.
27. McNamara JR & Schaefer EJ. (1987) Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clinica chimica acta; Int J Clin Che 166, 1-8.
28. Mendelson JH, Sholar MB, Mutschler NH, Jaszyna-Gasior M, Goletiani NV, Siegel AJ & Mello NK. (2003) Effects of intravenous cocaine and cigarette smoking on luteinizing hormone, testosterone, and prolactin in men. J Pharmacol Exp Therap 307, 339-348.
29. Mohr BA, Bhasin S, Link CL, O'Donnell AB & McKinlay JB. (2006) The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study. Eur J Endocrinol / Eur Federation Endocrine Soc 155, 443-452.
30. Morley JE, Kaiser FE, Perry HM, 3rd, Patrick P, Morley PM, Stauber PM, Vellas B, Baumgartner RN & Garry PJ. (1997) Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metab: Clin Exp 46, 410-413.
31. Muller M, den Tonkelaar I, Thijssen JH, Grobbee DE & van der Schouw YT. (2003a) Endogenous sex hormones in men aged 40-80years. Eur J Endocrinol / Eur Federation Endocrine Soc 149, 583-589.
32. Muller M, van derSchouw YT, Thijssen JH & Grobbee DE. (2003b) Endogenous sex hormones and cardiovascular disease in men. J Clin Endocrinol Metab 88, 5076-5086.
33. Rosner W, Auchus RJ, Azziz R, Sluss PM & Raff H. (2007) Utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. J Clin Endocrinol Metab 92, 405-413.
34. Sanders JL, Boudreau RM, Cappola AR, Arnold AM, Robbins J, Cushman M & Newman AB. (2010) Cardiovascular disease is associated with greater incident dehydroepiandrosterone sulfate decline in the oldest old: the cardiovascular health study all stars study. J Am Geriatr Soc 58, 421-426.
35. Schipf S, Haring R, Friedrich N, Nauck MA, Lau K, Alte D, Stang A, Völzke H & Wallaschofski H. (2011) Low total testosterone is associated with increased risk of incident type 2 diabetes mellitus in men: results from the Study of Health in Pomerania (SHIP). Aging Male 14, 168-175.
36. Snyder PJ. (2008) Decreasing testosterone with increasing age: more factors, more questions. J Clin Endocrinol Metab 93, 2477-2478.
37. Svartberg J, Midtby M, Bonaa KH, Sundsfjord J, Joakimsen RM & Jorde R. (2003) The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromso Study. Eur J Endocrinol / Eur Federation Endocrine Soc 149, 145-152.
38. Svartberg J, von Muhlen D, Mathiesen E, Joakimsen O, Bonaa KH & Stensland-Bugge E. (2006) Low testosterone levels are associated with carotid atherosclerosis in men. J Intern Med 259, 576-582.
39. Torkler S, Wallaschofski H, Baumeister SE, Volzke H, Dorr M, Felix S, Rettig R, Nauck M & Haring R. (2011) Inverse association between total testosterone concentrations, incident hypertension and blood pressure. Aging Male 14, 176-182.
40. Travison TG, Araujo AB, Kupelian V, O'Donnell AB & McKinlay JB. (2007a) The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab 92, 549-555.
41. Travison TG, Araujo AB, O'Donnell AB, Kupelian V & McKinlay JB. (2007b) A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab 92, 196-202.
42. Vermeulen A, Kaufman JM & Giagulli VA. (1996) Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 81, 1821-1826.
43. Vikan T, Johnsen SH, Schirmer H, Njolstad I & Svartberg J. (2009) Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromso study. Eur J Epidemiol 24, 289-295.
44. Vikan T, Schirmer H, Njolstad I & Svartberg J. (2010) Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men. Eur J Endocrinol / Eur Federation Endocrine Soc 162, 747-754.
45. Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW et al. (2008) Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 93, 2737-2745.
46. Yarnell JW, Beswick AD, Sweetnam PM & Riad-Fahmy D. (1993) Endogenous sex hormones and ischemic heart disease in men. The Caerphilly prospective study. Arterioscler Thromb 13, 517-520.
47. Yasui T, Uemura H, Irahara M, Arai M, Kojimahara N, Okabe R, Ishii Y, Tashiro S & Sato H. (2008) Associations of endogenous sex hormones and sex hormone-binding globulin with lipid profiles in aged Japanese men and women. Clinica chimica acta; Int J Clin Chem 398, 43-47.
48. Yeap BB. (2009) Are declining testosterone levels a major risk factor for ill-health in aging men? Int J Impot Res 21, 24-36.
49. Zmuda JM, Cauley JA, Kriska A, Glynn NW, Gutai JP & Kuller LH. (1997) Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. Am J Epidemiol 146, 609-617.